Pacific Bio (PACB) Tops Q3 EPS by 3c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $38.4 million versus the consensus estimate of $40.13 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Prologis makes unsolicited bid for SEGRO, valued at £12.6 billion
• Nokia and AWS expand collaboration on autonomous network platform